Strontium based Astragalus polysaccharides promote osteoblasts differentiation and mineralization

Int J Biol Macromol. 2022 Apr 30:205:761-771. doi: 10.1016/j.ijbiomac.2022.03.088. Epub 2022 Mar 19.

Abstract

Bone formation and repair represent a clinical challenge. In this work, we designed and synthesized strontium Astragalus polysaccharide (APS-Sr), a novel polysaccharide compound that should have therapeutic effects on both anti-inflammation and promoting bone formation. Using material characterization techniques, including SEM, FITR, XRD, etc., we verified the successful synthesis of this compound. Moreover, we examined the potential of this compound for promoting bone repair and inhibiting inflammatory response by cell proliferation assay, ALP and Alizarin Red staining experiments and RT-qPCR. The biological experiment results showed that APS-Sr can effectively inhibit inflammatory factors, promote osteogenic differentiation and up-regulate the bone growth factors. It is therefore believed that APS-Sr should be a promising polysaccharide compound in bone-related biomedical applications.

Keywords: Astragalus polysaccharide; Bone; Inflammatory; MC3T3-E1.

MeSH terms

  • Cell Differentiation
  • Osteoblasts
  • Osteogenesis*
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology
  • Strontium* / metabolism
  • Strontium* / pharmacology

Substances

  • Polysaccharides
  • Strontium